- Home
- CRDF vs AREN Comparison
CRDF vs AREN Comparison
Compare CRDF & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDF | AREN |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.7M | 109.0M |
| IPO Year | 2012 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CRDF | AREN |
|---|---|---|
| Price | $1.64 | $2.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $9.63 | $8.00 |
| AVG Volume (30 Days) | ★ 705.3K | 81.7K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.37 | ★ 191.93 |
| EPS | N/A | ★ 2.62 |
| Revenue | $365,993.00 | ★ $16,892,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.00 |
| P/E Ratio | ★ N/A | $1.06 |
| Revenue Growth | ★ 49.61 | 27.46 |
| 52 Week Low | $1.48 | $1.72 |
| 52 Week High | $4.56 | $10.05 |
Technical Indicators
Market Signals| Indicator | CRDF | AREN |
|---|---|---|
| Relative Strength Index (RSI) | 47.75 | 58.46 |
| Support Level | $1.51 | $2.15 |
| Resistance Level | $1.68 | $3.17 |
| Average True Range (ATR) | 0.09 | 0.25 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 25.01 | 74.26 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.
About AREN The Arena Group Holdings Inc.
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The company has four reportable segments: Sports & Leisure, Finance, Lifestyle, and Platform & Other. The company generates revenue from Sports & Leisure. Geographically, the company operates in United States; and Others. It generates maximum revenue from United States.